VIB9600 + Placebos

Phase 1Terminated

0 watching 0 views this week💤 Quiet

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Safety Issues

Conditions

Safety Issues

Trial Timeline

Aug 14, 2018 → Apr 8, 2019

NCT ID

NCT03621605

About VIB9600 + Placebos

VIB9600 + Placebos is a phase 1 stage product being developed by Amgen for Safety Issues. The current trial status is terminated. This product is registered under clinical trial identifier NCT03621605. Target conditions include Safety Issues.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT03621605	Phase 1	Terminated	Aug 14, 2018	Apr 8, 2019	Safety Issues

Competing Products

20 competing products in Safety Issues

See all competitors

Product	Company	Stage	Hype Score
LPH-5 + Placebo	Biotrial	Phase 1	25
DS-1971 + placebo	Daiichi Sankyo	Phase 1	33
ASP7962 + Placebo	Astellas Pharma	Phase 1	33
ASP2151 + Valacyclovir + Placebo	Astellas Pharma	Phase 1	33
AZD7986, oral solution, 1 to 50 mg/mL + Placebo, oral solution	AstraZeneca	Phase 1	33
Anifrolumab SC injection (300mg) + Anifrolumab IV infusion (300mg) + Anifrolumab SC infusion (600mg) + Anifrolumab placebo SC injection (300mg) + Anifrolumab placebo IV infusion (300mg) + Anifrolumab placebo SC infusion (600mg)	AstraZeneca	Phase 1	33
AZD7594 + Placebo to match	AstraZeneca	Phase 1	33
Anastrozole ODF + Arimidex tablet + Anastrozole ODF + Arimidex tablet	AstraZeneca	Phase 1	33
AZD4721 Solution + AZD4721 Placebo + AZD4721 Suspension	AstraZeneca	Phase 1	33
AZD9977, oral suspension + Placebo, oral suspension + AZD9977, oral solution	AstraZeneca	Phase 1	33
AZD3043	AstraZeneca	Phase 1	33
AZD8848 + Placebo to match AZD8848	AstraZeneca	Phase 1	33
AZD9567 Monohydrat + Placebo oral suspension/ Placebo capsule + Prednisolone	AstraZeneca	Phase 1	33
AZD7503 + Placebo	AstraZeneca	Phase 1	33
Fluad + Saline	Novartis	Approved	85
TBM100	Novartis	Approved	85
Denosumab	Amgen	Phase 3	76
Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil	Akeso	Phase 2	51
HTL0018318 + Placebo oral capsule	Nxera Pharma	Phase 1	32
Sildenafil + Placebo + Vardenafil (Levitra, BAY38-9456) + Placebo	Bayer	Approved	82

Other Products from Amgen